Description: The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Intermediate Products, Bulk Medicine, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings and organic fertilizers; holds trademarks; trades in pharmaceutical products; and engages in the food production activities. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
Home Page: www.tul.com.cn
6 Fuk Wang Street
Yuen Long,
Hong Kong
Phone:
852 2687 1033
Officers
| Name | Title |
|---|---|
| Mr. Hoi Shan Tsoi | Exec. Chairman |
| Mr. Wing Hon Leung CPA, FCPA | Vice Chairman, CFO & Company Sec. |
| Ms. Su Yan Zhu | VP & Exec. Director |
| Ms. Xian Hong Zou | VP & Exec. Director |
| Ms. Siu Chit Choy | Global Director of Intermediate & Bulk Medicine and Exec. Director |
| Mr. Yu Ping Fang | VP & Exec. Director |
| Ms. Karen Yang | Mang. of Investor Relations |
| Mr. Shou Ting Wu | Head of Production Plant -Zhongshan |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 5.9067 |
|---|---|
| Trailing PE: | 6.4613 |
| Price-to-Book MRQ: | 0.6719 |
| Price-to-Sales TTM: | 0.114 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 13600 |